Loading...
•
Jun 30, 2024
Celldex Q2 2024 Earnings Report
Reported financial results for the second quarter ended June 30, 2024 and provided a corporate update.
Key Takeaways
Celldex reported a net loss of $35.8 million, or ($0.54) per share, for the second quarter of 2024. The company's cash, cash equivalents and marketable securities totaled $802.3 million as of June 30, 2024, which is expected to fund operations through 2027. Total revenue was $2.5 million in the second quarter of 2024.
Cash, cash equivalents and marketable securities totaled $802.3 million as of June 30, 2024.
Total revenue was $2.5 million in the second quarter of 2024.
Research and development expenses were $39.7 million in the second quarter of 2024.
Net loss was $35.8 million, or ($0.54) per share, for the second quarter of 2024.
Forward Guidance
Celldex believes that the cash, cash equivalents and marketable securities at June 30, 2024 are sufficient to meet estimated working capital requirements and fund current planned operations through 2027.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...